![33964148_28_10_2022_2 [Converted]-01-01.png](https://static.wixstatic.com/media/6ef6c7_5f544a22d3e44e38864a07b9d0a57a38~mv2.png/v1/fill/w_980,h_102,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/6ef6c7_5f544a22d3e44e38864a07b9d0a57a38~mv2.png)
An article just published in the Journal of Surgical Research shows impressive benefits with F.O.A.M.™ deployment in a lethal, large-animal model of non-compressible abdominal bleeding. This is the first study to describe the use of a thermoresponsive foam to manage this important injury and it successfully demonstrated proof-of-concept feasibility. The intervention group demonstrated a significantly higher mean arterial pressure and an impressive trend toward improved survival (82% vs. 50% in controls). This injury pattern normally requires emergent surgery from a highly trained surgeon, while the F.O.A.M.™ device aims to shift intervention to earlier providers and settings. See full article here.
